Agata Cova

2.5k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Agata Cova is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Agata Cova has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Agata Cova's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (7 papers) and Extracellular vesicles in disease (5 papers). Agata Cova is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (7 papers) and Extracellular vesicles in disease (5 papers). Agata Cova collaborates with scholars based in Italy, United States and Qatar. Agata Cova's co-authors include Veronica Huber, Licia Rivoltini, Giorgio Parmiani, Paola Squarcina, Stefano Fais, Mario Santinami, Angelo De Milito, Paola Filipazzi, Arianna Calcinotto and Matteo Grioni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Agata Cova

23 papers receiving 1.2k citations

Hit Papers

Modulation of Microenvironment Acidity Reverses Anergy in... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
    2012 490 citations Arianna Calcinotto, Paola Filipazzi et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agata Cova Italy 12 664 571 422 320 126 24 1.2k
Xiaoqian Zhang China 6 874 1.3× 824 1.4× 636 1.5× 411 1.3× 160 1.3× 12 1.7k
Michele Minopoli Italy 17 479 0.7× 625 1.1× 261 0.6× 478 1.5× 116 0.9× 22 1.3k
Boxuan Zhou China 14 521 0.8× 717 1.3× 299 0.7× 438 1.4× 117 0.9× 40 1.4k
Varvara Petrova Italy 9 529 0.8× 254 0.4× 426 1.0× 412 1.3× 220 1.7× 10 1.2k
Yosra Messai France 13 411 0.6× 486 0.9× 453 1.1× 505 1.6× 108 0.9× 23 1.2k
Francis Mussai United Kingdom 18 438 0.7× 591 1.0× 284 0.7× 510 1.6× 93 0.7× 40 1.4k
Stephanie Grebinoski United States 7 383 0.6× 548 1.0× 327 0.8× 353 1.1× 120 1.0× 9 1.0k
Alessandra Boe Italy 21 693 1.0× 203 0.4× 412 1.0× 350 1.1× 98 0.8× 37 1.2k
Shweta Joshi United States 23 655 1.0× 403 0.7× 239 0.6× 382 1.2× 61 0.5× 48 1.5k
Taewon Yoon United States 7 1.2k 1.9× 470 0.8× 709 1.7× 512 1.6× 71 0.6× 7 1.7k

Countries citing papers authored by Agata Cova

Since Specialization
Citations

This map shows the geographic impact of Agata Cova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agata Cova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agata Cova more than expected).

Fields of papers citing papers by Agata Cova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agata Cova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agata Cova. The network helps show where Agata Cova may publish in the future.

Co-authorship network of co-authors of Agata Cova

This figure shows the co-authorship network connecting the top 25 collaborators of Agata Cova. A scholar is included among the top collaborators of Agata Cova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agata Cova. Agata Cova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Natsaridis, Evangelos, Agata Cova, Giovanni Lupoli, et al.. (2024). Reprogramming the melanoma and immunosuppressive myeloid cells with esomeprazole-loaded PLGA nanoparticles. iScience. 28(1). 111559–111559. 3 indexed citations
3.
4.
Fortunato, Orazio, Veronica Huber, Agata Cova, et al.. (2022). Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening. Cancer Epidemiology Biomarkers & Prevention. 31(11). 2020–2029. 3 indexed citations
5.
Rinchai, Darawan, Elena Verzoni, Veronica Huber, et al.. (2021). Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients. SHILAP Revista de lepidopterología. 11(6). e434–e434. 5 indexed citations
6.
Brunani, Amelia, Marco Arreghini, Agata Cova, et al.. (2021). Nutritional status in post SARS-Cov2 rehabilitation patients. Clinical Nutrition. 41(12). 3055–3060. 13 indexed citations
7.
Federici, Cristina, Eriomina Shahaj, Serena Cecchetti, et al.. (2020). Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors. Frontiers in Immunology. 11. 262–262. 125 indexed citations
8.
Verzoni, Elena, Eriomina Shahaj, Simona Frigerio, et al.. (2020). Selective modulation of immune transcripts in extracellular vesicles from plasma of renal cell carcinoma patients receiving nivolumab.. Journal of Clinical Oncology. 38(6_suppl). 719–719. 1 indexed citations
9.
Verzoni, Elena, Alessandra Bearz, Ugo De Giorgi, et al.. (2019). A phase II open-label study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pretreated with one immune-checkpoint inhibitor: The BREAKPOINT trial.. Journal of Clinical Oncology. 37(7_suppl). TPS685–TPS685. 1 indexed citations
10.
Verzoni, Elena, Agata Cova, Paola Squarcina, et al.. (2017). Broad immunomodulating effect of first-line Pazopanib in metastatic renal cell carcinoma patients. Annals of Oncology. 28. vi17–vi17. 1 indexed citations
11.
Verzoni, Elena, Loris De Cecco, Matteo Dugo, et al.. (2017). Broad immunomodulating effect of first-line pazopanib in metastatic renal cell carcinoma patients. Annals of Oncology. 28. v315–v315. 6 indexed citations
12.
Rivoltini, Licia, Claudia Chiodoni, Paola Squarcina, et al.. (2016). TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site. Clinical Cancer Research. 22(14). 3499–3512. 164 indexed citations
13.
Bossi, Paolo, Cristiana Bergamini, Rosalba Miceli, et al.. (2016). Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 96(5). 959–966. 60 indexed citations
14.
Huber, Veronica, Viviana Vallacchi, Lorenza Di Guardo, et al.. (2015). ITOC2 – 038. Role of exosomes in immune suppression. European Journal of Cancer. 51. S13–S13. 3 indexed citations
15.
Calcinotto, Arianna, Paola Filipazzi, Matteo Grioni, et al.. (2012). Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes. Cancer Research. 72(11). 2746–2756. 490 indexed citations breakdown →
16.
Martayan, Aline, Leonardo Sibilio, Elisa Tremante, et al.. (2009). Class I HLA Folding and Antigen Presentation in β2-Microglobulin-Defective Daudi Cells. The Journal of Immunology. 182(6). 3609–3617. 17 indexed citations
17.
Tosi, Diégo, Agata Cova, Gloria Sovena, et al.. (2004). Role of Cross-Talk between IFN-α-Induced Monocyte-Derived Dendritic Cells and NK Cells in Priming CD8+ T Cell Responses against Human Tumor Antigens. The Journal of Immunology. 172(9). 5363–5370. 78 indexed citations
18.
Rivoltini, Licia, Chiara Castelli, Matteo Giovanni Carrabba, et al.. (2003). Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells. The Journal of Immunology. 171(7). 3467–3474. 93 indexed citations
19.
Lozupone, Francesco, Licia Rivoltini, Francesca Luciani, et al.. (2003). Adoptive transfer of an anti‐MART‐127–35‐specific CD8+ T cell clone leads to immunoselection of human melanoma antigen‐loss variants in SCID mice. European Journal of Immunology. 33(2). 556–566. 38 indexed citations
20.
Bo, Roberto Del, Yvan Torrente, Stefania Corti, et al.. (2001). In Vitro and In Vivo Tetracycline-Controlled Myogenic Conversion of NIH-3T3 Cells: Evidence of Programmed Cell Death after Muscle Cell Transplantation. Cell Transplantation. 10(2). 209–221. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoqian Zhang Breakdown of academic impact, for papers by Michele Minopoli Breakdown of academic impact, for papers by Boxuan Zhou Breakdown of academic impact, for papers by Varvara Petrova Breakdown of academic impact, for papers by Yosra Messai Breakdown of academic impact, for papers by Francis Mussai Breakdown of academic impact, for papers by Stephanie Grebinoski Breakdown of academic impact, for papers by Alessandra Boe Breakdown of academic impact, for papers by Shweta Joshi Breakdown of academic impact, for papers by Taewon Yoon
Rankless by CCL
2026